We partner with US and global medical affairs teams through a product’s life cycle to facilitate optimal collaboration between internal teams, physicians, and the broader medical community. This ...

Integration and creativity are at the core of our healthcare approach. Aided by our consumer driven insight, derived from our experience outside healthcare, we add an extra dimension in a regulated ...

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a global scale. We also syndicate our video library in ...

Arke Data Analysis offer cost-effective, academic quality research for the pharmaceutical sector. All team members hold a PhD in a health-related field. Services include; systematic and structured ...

We are a key player in the regulatory/NPD services sector consisting of well-seasoned professionals with in-depth exposure to practically all aspects of medicinal product development with a primary ...

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our planet. But are those connections working for or against your… ...

AbbVie’s Parkinson’s disease (PD) therapy has been approved by the US Food and Drug Administration (FDA) to treat motor ...

Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024 ...

Inizio Medical has announced the appointment of Matt Wadyka as president, US medical affairs. In this newly created role, ...

Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director Innovative Trials have ...

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat • Mtech Access and ...

Pfizer has announced positive overall survival (OS) results from a late-stage study of its prostate cancer combination treatment. The phase 3 TALAPRO-2 trial has been evaluating the drugmaker’s PARP ...